People

Rodrigo Silva

senior researcher

Email
rodrigo.silva@vicaima.pt
ORCID
0000-0001-7579-0041
Ciência Vitae
FF15-DD36-8DD3

Recent publications

  • Correia, A; Costa, CP; Silva, V; Silva, R; Lobo, JMS; Silva, AC. 2020. Pessaries containing nanostructured lipid carriers (NLC) for prolonged vaginal delivery of progesterone. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 153, DOI: 10.1016/j.ejps.2020.105475
  • Silva, VLS; Silva, R; Gil-Martins, E; Sousa, E; Resende, D; Remiao, F; Rocha-Pereira, C. 2019. Xanthones as potential P-glycoprotein modulators at the intestinal barrier: in vitro and ex vivo studies. TOXICOLOGY LETTERS, 314, DOI:
  • Pinto, M; Fernandes, C; Gil-Martins, E; Silva, R; Benfeito, S; Cagide, F; Borges, F; Remiao, F. 2019. Bioavailability improvement of a monoamine oxidase-B inhibitor using PEGylated PCL-based nanoparticles. TOXICOLOGY LETTERS, 314, DOI:
  • Gil-Martins, E; Barbosa, DJ; Sousa, E; Resende, D; Remiao, F; Silva, R. 2019. P-glycoprotein modulation by xanthonic derivatives: a strategy to fight Alzheimer's disease. TOXICOLOGY LETTERS, 314, DOI:
  • Benfeito, S; Oliveira, C; Fernandes, C; Cagide, F; Teixeira, J; Amorim, R; Garrido, J; Martins, C; Sarmento, B; Silva, R; Remiao, F; Uriarte, E; Oliveira, PJ; Borges, F. 2019. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 167, DOI: 10.1016/j.ejmech.2019.01.055